Selected research
Industry Growth & Trends
Global Viral Vector CTDMO Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Viral Vector CTDMO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Viral Vector CTDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Viral Vector CTDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Viral Vector CTDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Viral Vector CTDMO Services market include AGC Biologics, Lonza, Charles River Laboratories, Thermo Fisher Scientific, SK pharmteco, Batavia Biosciences, HALIX, Catalent Biologics and Oxford BioMedica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Viral Vector CTDMO Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Viral Vector CTDMO Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Viral Vector CTDMO Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Viral Vector CTDMO Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Viral Vector CTDMO Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Viral Vector CTDMO Services Market by Company
AGC Biologics
Lonza
Charles River Laboratories
Thermo Fisher Scientific
SK pharmteco
Batavia Biosciences
HALIX
Catalent Biologics
Oxford BioMedica
Biovian
Viral Vector CTDMO Services Segment by Type
Adeno-associated Viral
Adenoviral
Lentiviral
Retroviral
Viral Vector CTDMO Services Segment by Application
Gene Therapy
Cell Therapy
Vaccine Development
Viral Vector CTDMO Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Vector CTDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Vector CTDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Vector CTDMO Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Viral Vector CTDMO Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Adeno-associated Viral
- Adenoviral
- Lentiviral
- Retroviral
Applications
- Gene Therapy
- Cell Therapy
- Vaccine Development
Companies covered
- AGC Biologics
- Lonza
- Charles River Laboratories
- Thermo Fisher Scientific
- SK pharmteco
- Batavia Biosciences
- HALIX
- Catalent Biologics
- Oxford BioMedica
- Biovian
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Viral Vector CTDMO Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Viral Vector CTDMO Services Market Size by Region (2021-2032)
- 1.4.1 Global Viral Vector CTDMO Services Market Size by Region (2021-2026)
- 1.4.2 Global Viral Vector CTDMO Services Market Size by Region (2027-2032)
- 1.5 Key Regions Viral Vector CTDMO Services Market Size (2021-2032)
- 1.5.1 North America Viral Vector CTDMO Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Viral Vector CTDMO Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Viral Vector CTDMO Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Viral Vector CTDMO Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Viral Vector CTDMO Services Market Size Growth Rate (2021-2032)
2 Viral Vector CTDMO Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Adeno-associated Viral
- 2.1.2 Adenoviral
- 2.1.3 Lentiviral
- 2.1.4 Retroviral
- 2.2 Global Viral Vector CTDMO Services Market Size by Type
- 2.2.1 Global Viral Vector CTDMO Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Viral Vector CTDMO Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Viral Vector CTDMO Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Viral Vector CTDMO Services Market Size by Regions
- 2.3.1 North America Viral Vector CTDMO Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Viral Vector CTDMO Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Viral Vector CTDMO Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Viral Vector CTDMO Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Viral Vector CTDMO Services Market Size Breakdown by Type (2021-2026)
3 Viral Vector CTDMO Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Gene Therapy
- 3.1.2 Cell Therapy
- 3.1.3 Vaccine Development
- 3.2 Global Viral Vector CTDMO Services Market Size by Application
- 3.2.1 Global Viral Vector CTDMO Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Viral Vector CTDMO Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Viral Vector CTDMO Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Viral Vector CTDMO Services Market Size by Regions
- 3.3.1 North America Viral Vector CTDMO Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Viral Vector CTDMO Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Viral Vector CTDMO Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Viral Vector CTDMO Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Viral Vector CTDMO Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Viral Vector CTDMO Services Industry Trends
- 4.2 Viral Vector CTDMO Services Industry Drivers
- 4.3 Viral Vector CTDMO Services Industry Opportunities and Challenges
- 4.4 Viral Vector CTDMO Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Viral Vector CTDMO Services Revenue (2021-2026)
- 5.2 Global Viral Vector CTDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Viral Vector CTDMO Services Key Company Headquarters & Area Served
- 5.4 Global Viral Vector CTDMO Services Company, Product Type & Application
- 5.5 Global Viral Vector CTDMO Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Viral Vector CTDMO Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Viral Vector CTDMO Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Viral Vector CTDMO Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AGC Biologics
- 6.1.1 AGC Biologics Company Information
- 6.1.2 AGC Biologics Business Overview
- 6.1.3 AGC Biologics Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AGC Biologics Viral Vector CTDMO Services Product Portfolio
- 6.1.5 AGC Biologics Recent Developments
- 6.2 Lonza
- 6.2.1 Lonza Company Information
- 6.2.2 Lonza Business Overview
- 6.2.3 Lonza Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Lonza Viral Vector CTDMO Services Product Portfolio
- 6.2.5 Lonza Recent Developments
- 6.3 Charles River Laboratories
- 6.3.1 Charles River Laboratories Company Information
- 6.3.2 Charles River Laboratories Business Overview
- 6.3.3 Charles River Laboratories Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Charles River Laboratories Viral Vector CTDMO Services Product Portfolio
- 6.3.5 Charles River Laboratories Recent Developments
- 6.4 Thermo Fisher Scientific
- 6.4.1 Thermo Fisher Scientific Company Information
- 6.4.2 Thermo Fisher Scientific Business Overview
- 6.4.3 Thermo Fisher Scientific Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Thermo Fisher Scientific Viral Vector CTDMO Services Product Portfolio
- 6.4.5 Thermo Fisher Scientific Recent Developments
- 6.5 SK pharmteco
- 6.5.1 SK pharmteco Company Information
- 6.5.2 SK pharmteco Business Overview
- 6.5.3 SK pharmteco Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 SK pharmteco Viral Vector CTDMO Services Product Portfolio
- 6.5.5 SK pharmteco Recent Developments
- 6.6 Batavia Biosciences
- 6.6.1 Batavia Biosciences Company Information
- 6.6.2 Batavia Biosciences Business Overview
- 6.6.3 Batavia Biosciences Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Batavia Biosciences Viral Vector CTDMO Services Product Portfolio
- 6.6.5 Batavia Biosciences Recent Developments
- 6.7 HALIX
- 6.7.1 HALIX Company Information
- 6.7.2 HALIX Business Overview
- 6.7.3 HALIX Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 HALIX Viral Vector CTDMO Services Product Portfolio
- 6.7.5 HALIX Recent Developments
- 6.8 Catalent Biologics
- 6.8.1 Catalent Biologics Company Information
- 6.8.2 Catalent Biologics Business Overview
- 6.8.3 Catalent Biologics Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Catalent Biologics Viral Vector CTDMO Services Product Portfolio
- 6.8.5 Catalent Biologics Recent Developments
- 6.9 Oxford BioMedica
- 6.9.1 Oxford BioMedica Company Information
- 6.9.2 Oxford BioMedica Business Overview
- 6.9.3 Oxford BioMedica Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Oxford BioMedica Viral Vector CTDMO Services Product Portfolio
- 6.9.5 Oxford BioMedica Recent Developments
- 6.10 Biovian
- 6.10.1 Biovian Company Information
- 6.10.2 Biovian Business Overview
- 6.10.3 Biovian Viral Vector CTDMO Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Biovian Viral Vector CTDMO Services Product Portfolio
- 6.10.5 Biovian Recent Developments
7 North America
- 7.1 North America Viral Vector CTDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 7.3 North America Viral Vector CTDMO Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Viral Vector CTDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 8.3 Europe Viral Vector CTDMO Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Viral Vector CTDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Viral Vector CTDMO Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Viral Vector CTDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 10.3 South America Viral Vector CTDMO Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Viral Vector CTDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Viral Vector CTDMO Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst